Members of the RhoA family have been extensively examined as targets for hypertension therapy [42], and given its upregulation in AA women with hypertension (shown here and in [9]), the targeting of elevated RHOA expression and the downstream impact on cytoskeleton function may be a novel area for intervention in AA women. The gene discussed is RHOA; the disease is hypertensive disorder.